bf/NASDAQ:TENX_icon.jpeg

NASDAQ:TENX

Tenax Therapeutics, Inc.

  • Stock

USD

Last Close

3.59

16/05 20:00

Market Cap

3.01M

Beta: 2.17

Volume Today

31.65K

Avg: 3.72M

PE Ratio

−20.44

PFCF: −0.36

Apr '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
250.58K
-
200.98K
19.79%
average payables
694.15K
-
691.81K
0.34%
850.04K
22.87%
669.73K
21.21%
680.84K
1.66%
1.21M
77.05%
1.21M
0.33%
808.75K
33.13%
654.03K
19.13%
1.26M
92.77%
average receivables
303.79K
-
57.78K
80.98%
61.02K
5.62%
61.38K
0.59%
25.09K
59.13%
book value per share
3.54K
-
860.81
75.69%
243.83
71.67%
125.93
48.35%
150.46
19.48%
12.18
91.91%
8.92
26.72%
4.13
53.77%
1.01
75.41%
32.59
3,112.68%
capex per share
-6.28
-
-1.56
75.13%
-0.04
97.37%
-0.06
56.80%
-0.10
50.91%
-0.01
88.11%
-0.01
41.64%
-0.01
24.19%
-0.00
69.07%
0.01
824.76%
capex to depreciation
-0.98
-
-0.74
24.24%
-0.15
79.44%
-0.33
118.89%
-0.84
152.90%
-0.03
96.05%
-0.03
8.71%
-0.05
58.45%
-0.02
57.47%
0.38
1,932.25%
capex to operating cash flow
0.02
-
0.01
29.15%
0.00
98.38%
0.00
105.66%
0.00
269.55%
0.00
65.75%
0.00
20.43%
0.00
28.54%
0.00
60.03%
-0.00
349.04%
capex to revenue
-0.51
-
-2.22
336.89%
cash per share
2.49K
-
287.62
88.46%
188.92
34.32%
109.56
42.01%
164.40
50.05%
17.43
89.40%
12.95
25.70%
5.43
58.10%
1.44
73.40%
39.41
2,630.59%
days of inventory on hand
1.13K
-
days payables outstanding
1.16K
-
days sales outstanding
83.57
-
366.20
338.18%
debt to assets
0.00
-
0.00
63.04%
0.03
-
0.04
64.60%
0.05
9.27%
0.24
388.99%
debt to equity
0.00
-
0.00
60.39%
0.05
-
0.07
44.87%
0.07
3.88%
0.54
690.03%
dividend yield
3.87
-
earnings yield
-0.43
-
-0.15
64.25%
-0.80
423.88%
-0.64
20.17%
-3.56
456.18%
-0.96
72.98%
-0.51
46.72%
-1.53
198.73%
-3.38
121.06%
1.41
141.78%
enterprise value
-12.29M
-
88.53M
820.55%
44.84M
49.36%
12.22M
72.75%
-10.47M
185.72%
4.00M
138.20%
13.34M
233.27%
16.11M
20.79%
1.95M
87.89%
-4.33M
322.19%
enterprise value over ebitda
0.75
-
-6.49
969.95%
-2.32
64.35%
-1.33
42.58%
1.52
214.45%
-0.47
131.13%
-1.37
189.21%
-0.50
63.67%
-0.18
64.14%
-0.56
214.96%
ev to operating cash flow
1.33
-
-9.08
784.53%
-2.83
68.89%
-1.01
64.37%
1.90
289.23%
-0.53
127.80%
-1.44
171.57%
-1.48
3.17%
-0.16
89.06%
0.73
552.12%
ev to sales
-42.56
-
1.80K
4,321.08%
free cash flow per share
-401.99
-
-140.45
65.06%
-225.81
60.78%
-172.19
23.74%
-70.39
59.12%
-24.40
65.33%
-17.90
26.66%
-10.56
41.02%
-8.17
22.64%
-23.75
190.83%
free cash flow yield
-0.21
-
-0.11
48.02%
-0.29
170.44%
-0.88
203.47%
-2.91
231.07%
-0.87
70.25%
-0.48
44.40%
-0.51
5.49%
-3.68
624.78%
-1.08
70.61%
graham net net
2.05K
-
109.16
94.68%
101.51
7.01%
95.79
5.63%
144.38
50.73%
9.06
93.72%
8.62
4.83%
3.73
56.76%
0.14
96.14%
24.98
17,258.14%
graham number
8.16K
-
1.97K
75.83%
1.85K
6.07%
595.91
67.81%
539.78
9.42%
86.17
84.04%
61.84
28.23%
54.34
12.13%
13.09
75.91%
150.87
1,052.57%
income quality
0.47
-
0.69
46.07%
0.36
47.81%
1.37
280.09%
0.39
71.69%
0.90
131.51%
0.94
4.57%
0.33
64.48%
1.09
225.26%
0.77
29.59%
intangibles to total assets
0.37
-
0.46
24.27%
0
100%
0
0
0
0
0
0
0
interest coverage
-7.51
-
-301.88
3,920.51%
-1.62
99.46%
-6.07K
-
-34.49K
468.61%
-2.49K
92.79%
321.72
112.93%
interest debt per share
109.34
-
2.13
98.06%
462.32
21,644.58%
0.55
-
0.59
6.73%
0.28
52.08%
0.55
94.72%
0.10
82.53%
inventory turnover
0.32
-
invested capital
0.00
-
0.00
60.39%
0.05
-
0.07
44.87%
0.07
3.88%
0.54
690.03%
market cap
45.69M
-
92.09M
101.58%
54.83M
40.46%
13.82M
74.79%
1.89M
86.30%
8.74M
361.38%
19.28M
120.71%
21.40M
11.00%
3.27M
84.74%
5.46M
67.11%
net current asset value
48.42M
-
8.00M
83.49%
7.43M
7.10%
7.05M
5.05%
11.75M
66.64%
3.59M
69.48%
4.55M
26.88%
3.94M
13.42%
1.30M
67.11%
8.10M
524.53%
net debt to ebitda
3.52
-
0.26
92.59%
0.52
97.65%
0.17
66.18%
1.80
929.01%
0.56
68.81%
0.61
8.98%
0.16
73.22%
0.12
26.39%
-1.27
1,154.93%
net income per share
-834.94
-
-200.61
75.97%
-624.82
211.45%
-125.33
79.94%
-86.07
31.33%
-27.10
68.51%
-19.05
29.72%
-31.81
67.03%
-7.51
76.41%
31.04
513.49%
operating cash flow per share
-395.71
-
-138.88
64.90%
-225.77
62.56%
-172.13
23.76%
-70.29
59.16%
-24.39
65.30%
-17.89
26.65%
-10.55
41.02%
-8.16
22.62%
-23.76
191.03%
payables turnover
0.32
-
receivables turnover
4.37
-
1.00
77.18%
research and ddevelopement to revenue
10.38
-
135.14
1,202.01%
return on tangible assets
-0.33
-
-0.35
7.33%
-1.88
430.85%
-0.89
52.51%
-0.50
43.51%
-1.32
161.21%
-1.44
8.97%
-5.46
280.07%
-3.24
40.62%
0.66
120.35%
revenue per share
12.34
-
0.70
94.31%
roe
-0.24
-
-0.23
1.15%
-2.56
999.54%
-1.00
61.16%
-0.57
42.52%
-2.23
288.99%
-2.13
4.09%
-7.71
261.33%
-7.40
4.06%
0.95
112.87%
roic
-0.21
-
-0.25
20.42%
-2.60
943.57%
-0.99
61.79%
-0.58
41.75%
-2.08
259.16%
-1.98
4.69%
-6.83
244.99%
-4.45
34.93%
0.95
121.41%
sales general and administrative to revenue
47.70
-
145.49
204.99%
shareholders equity per share
3.54K
-
860.81
75.69%
243.83
71.67%
125.93
48.35%
150.46
19.48%
12.18
91.91%
8.92
26.72%
4.13
53.77%
1.01
75.41%
32.59
3,112.68%
stock based compensation to revenue
2.26
-
2.38
5.48%
tangible asset value
48.62M
-
27.16M
44.14%
17.14M
36.88%
8.88M
48.18%
11.77M
32.53%
3.77M
67.95%
4.63M
22.61%
4.24M
8.23%
1.49M
64.83%
8.10M
442.50%
tangible book value per share
2.08K
-
386.90
81.38%
243.83
36.98%
125.93
48.35%
150.46
19.48%
12.18
91.91%
8.92
26.72%
4.13
53.77%
1.01
75.41%
32.59
3,112.68%
working capital
56.39M
-
15.96M
71.70%
7.43M
53.45%
7.05M
5.05%
11.75M
66.64%
3.65M
68.96%
4.68M
28.18%
4.13M
11.79%
1.36M
67.01%
8.10M
495.06%

All numbers in USD (except ratios and percentages)